Article

Plasma Proteomics for Parkinson’s Disease: Diagnostic Classification, Severity Association, and Therapeutic Hypotheses

2025-09-04

Abstract excerpt

<h4>Background</h4> Although there is no cure, early diagnosis of Parkinson’s disease allows effective management and symptomatic relief, potentially delaying the need for more potent medications. Blood-based biomarkers can facilitate early detection, symptom monitoring, and targeted therapy. <h4>Methods</h4> Gene expression and plasma proteomics data from two Parkinson’s disease cohorts were integrated. Machine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2cd9492a-3f05-530d-9f8e-859fc3c40e20
DOI: 10.1101/2025.09.02.25334526

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Plasma Proteomics for Parkinson’s Disease: Diagnostic Classification, Severity Association, and Therapeutic HypothesesDOI 10.1101/2025.09.02.25334526Read

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluidSemantic proximity Read

Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal dataSemantic proximity Read

Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s DiseaseSemantic proximity Read

Identification of a novel proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSFSemantic proximity Read

Identification of Parkinson PACE subtypes and repurposing treatments through integrative analyses of multimodal clinical progression, neuroimaging, genetic, and transcriptomic dataSemantic proximity Read

Transcriptomics profiling of Parkinson’s disease progression subtypes reveals distinctive patterns of gene expressionSemantic proximity Read

Parkinson’s Disease motor and non-motor progression models emerge from pathway-level transcriptomicsSemantic proximity Read

Integrating plasma circulating protein-centered multi-omics to identify potential therapeutic targets for Parkinsonian cognitive disordersSemantic proximity Read

Mapping Parkinson’s Disease Progression through Deep Plasma Proteomics and Functional GenomicsSemantic proximity Read

Plasma acellular transcriptome contains Parkinson’s disease signatures that can inform clinical diagnosisSemantic proximity Read

From Neural Connectopathy to a Therapeutic Path: An Integrated Multi-omics Framework Identifies a Causal Gene and Drug Candidates for Parkinson's Disease with mild cognitive impairmentSemantic proximity Read

Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validationSemantic proximity Read